CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biocon Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biocon Ltd
20th KM, Hosur Road, Electronic City,
Phone: +91 8028082808p:+91 8028082808 BANGALORE, 560100  India Ticker: BIOCONBIOCON
Business Summary
Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairperson of the Board KiranMazumdarshaw 70 4/1/2020
Chief Executive Officer, Managing Director, Executive Director SiddharthMittal 45 4/1/2020 8/1/2014
Group Chief Executive Officer Peter J.Bains 66 9/18/2023 12/12/2022
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Biocon Biologics UK Ltd 16 GREAT QUEEN STREET COVENT GARDEN United Kingdom
Biocon Pharma Ltd. 20th KM, Hosur Road, Electronics City BANGALORE India
BIOCON BIOLOGICS INDIA LIMITED BIOCON HOUSE, GROUND FLOOR,TOWER-3, SEMICON PARK,ELECTRONIC KARNATAKA INDIA
Biocon Biologics Ltd Biocon House, Semicon Park Karnataka India

Business Names
Business Name
532523
BIOCON
BIOCON BIOLOGICS UK LIMITED
Biocon Limited

General Information
Number of Employees: 3,408 (As of 3/31/2023)
Outstanding Shares: 1,196,804,982 (As of 3/31/2024)
Shareholders: 421,688
Stock Exchange: NSE
Fax Number: +91 8028523423


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024